217 related articles for article (PubMed ID: 27769062)
1. Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp/Irf8), growth arrest specific 2 (Gas2) and calpain.
Hjort EE; Huang W; Hu L; Eklund EA
Oncotarget; 2016 Nov; 7(47):77635-77650. PubMed ID: 27769062
[TBL] [Abstract][Full Text] [Related]
2. Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription.
Huang W; Zhou W; Saberwal G; Konieczna I; Horvath E; Katsoulidis E; Platanias LC; Eklund EA
Mol Cell Biol; 2010 Oct; 30(19):4575-94. PubMed ID: 20679491
[TBL] [Abstract][Full Text] [Related]
3. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder.
Hao SX; Ren R
Mol Cell Biol; 2000 Feb; 20(4):1149-61. PubMed ID: 10648600
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemia.
Waight JD; Banik D; Griffiths EA; Nemeth MJ; Abrams SI
J Biol Chem; 2014 May; 289(22):15642-52. PubMed ID: 24753251
[TBL] [Abstract][Full Text] [Related]
5. The Interferon Consensus Sequence Binding Protein (Icsbp/Irf8) Is Required for Termination of Emergency Granulopoiesis.
Hu L; Huang W; Hjort EE; Bei L; Platanias LC; Eklund EA
J Biol Chem; 2016 Feb; 291(8):4107-20. PubMed ID: 26683374
[TBL] [Abstract][Full Text] [Related]
6. Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2.
Burchert A; Cai D; Hofbauer LC; Samuelsson MK; Slater EP; Duyster J; Ritter M; Hochhaus A; Müller R; Eilers M; Schmidt M; Neubauer A
Blood; 2004 May; 103(9):3480-9. PubMed ID: 14656881
[TBL] [Abstract][Full Text] [Related]
7. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias.
Schmidt M; Nagel S; Proba J; Thiede C; Ritter M; Waring JF; Rosenbauer F; Huhn D; Wittig B; Horak I; Neubauer A
Blood; 1998 Jan; 91(1):22-9. PubMed ID: 9414265
[TBL] [Abstract][Full Text] [Related]
8. The interferon consensus sequence-binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells.
Huang W; Zhu C; Wang H; Horvath E; Eklund EA
J Biol Chem; 2008 Mar; 283(12):7921-35. PubMed ID: 18195016
[TBL] [Abstract][Full Text] [Related]
9. Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth.
Zhou H; Ge Y; Sun L; Ma W; Wu J; Zhang X; Hu X; Eaves CJ; Wu D; Zhao Y
PLoS One; 2014; 9(1):e86195. PubMed ID: 24465953
[TBL] [Abstract][Full Text] [Related]
10. Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML).
Scherr M; Chaturvedi A; Battmer K; Dallmann I; Schultheis B; Ganser A; Eder M
Blood; 2006 Apr; 107(8):3279-87. PubMed ID: 16278304
[TBL] [Abstract][Full Text] [Related]
11. Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr-abl oncogene.
Huang W; Bei L; Eklund EA
Leuk Lymphoma; 2013 Mar; 54(3):619-30. PubMed ID: 22891763
[TBL] [Abstract][Full Text] [Related]
12. ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells.
Tamura T; Kong HJ; Tunyaplin C; Tsujimura H; Calame K; Ozato K
Blood; 2003 Dec; 102(13):4547-54. PubMed ID: 12933588
[TBL] [Abstract][Full Text] [Related]
13. Positive interactions between STAP-1 and BCR-ABL influence chronic myeloid leukemia cell proliferation and survival.
Ishiura M; Kitai Y; Kashiwakura JI; Muromoto R; Toda J; Ichii M; Oritani K; Matsuda T
Biochem Biophys Res Commun; 2021 Jun; 556():185-191. PubMed ID: 33845308
[TBL] [Abstract][Full Text] [Related]
14. BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia.
Hantschel O; Warsch W; Eckelhart E; Kaupe I; Grebien F; Wagner KU; Superti-Furga G; Sexl V
Nat Chem Biol; 2012 Jan; 8(3):285-93. PubMed ID: 22286129
[TBL] [Abstract][Full Text] [Related]
15. Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells.
Chatain N; Ziegler P; Fahrenkamp D; Jost E; Moriggl R; Schmitz-Van de Leur H; Müller-Newen G
Oncogene; 2013 Aug; 32(31):3587-97. PubMed ID: 22926520
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R
Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses.
Bourgeais J; Ishac N; Medrzycki M; Brachet-Botineau M; Desbourdes L; Gouilleux-Gruart V; Pecnard E; Rouleux-Bonnin F; Gyan E; Domenech J; Mazurier F; Moriggl R; Bunting KD; Herault O; Gouilleux F
Oncotarget; 2017 Jun; 8(26):41876-41889. PubMed ID: 27566554
[TBL] [Abstract][Full Text] [Related]
18. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway.
Wang X; Yang J; Guo G; Feng R; Chen K; Liao Y; Zhang L; Sun L; Huang S; Chen JL
Mol Cancer; 2019 Apr; 18(1):84. PubMed ID: 30961617
[TBL] [Abstract][Full Text] [Related]
19. Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia.
Minieri V; De Dominici M; Porazzi P; Mariani SA; Spinelli O; Rambaldi A; Peterson LF; Porcu P; Nevalainen MT; Calabretta B
Cancer Res; 2018 Oct; 78(20):5793-5807. PubMed ID: 30154155
[TBL] [Abstract][Full Text] [Related]
20. Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.
Gleixner KV; Schneeweiss M; Eisenwort G; Berger D; Herrmann H; Blatt K; Greiner G; Byrgazov K; Hoermann G; Konopleva M; Waliul I; Cumaraswamy AA; Gunning PT; Maeda H; Moriggl R; Deininger M; Lion T; Andreeff M; Valent P
Haematologica; 2017 Sep; 102(9):1519-1529. PubMed ID: 28596283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
